A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal ...

To our knowledge, this is the first report of a pharmacy program implemented to improve the outcomes of an S. aureus decolonization protocol. After implementation of the program, adherence to nasal ...

Treating Staphylococcus aureus colonization in patients prior to surgery is a common step to prevent surgical site infections, but patients do not always follow the multistep application instructions ...

The objective of this study was to determine whether use of mupirocin nasal ointment for perioperative eradication of Staphylococcus aureus nasal carriage is effective in preventing the development of ...

NEW YORK (Reuters Health) - In patients with hay fever, a nasal ointment containing the antibiotic mupirocin can eliminate Staphylococcus aureus bacteria in the nose, but this does not improve ...

Please provide your email address to receive an email when new articles are posted on . “Mupirocin is the gold-standard topical treatment for nasal decolonization, but there are reports of increasing ...

SAN DIEGO, CA—Clinicians should consider nasal povidone-iodine as an alternative to nasal mupirocin ointment to reduce risk of deep Staphylococcus aureus surgical site infections (SSI) following ...

A team of doctors has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus ...

A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), has performed a clinical trial involving ...

Data were collected for seven months before program implementation and seven months after program implementation. During the preimplementation period, 8917 patients were admitted to one of the ...

BALTIMORE, MD, Dec. 26, 2018 -- A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), has ...